Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board

/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today...

Related Keywords

Israel ,Shanghai ,China ,United States ,Chinese ,American ,Opdivo Nivolumab ,Rita Laeufle ,Technology Progress ,Technology Award ,Phanes Therapeutics Inc ,Board Member Of Anticancer Association ,Shanghai Jiao Tong University ,American Clinical Oncology Society ,Tel Aviv University ,Committee Member ,Shanghai Jiao Tong University Chest Hospital ,Md Anderson Cancer Center ,International Affairs Committee ,Prnewswire Phanes Therapeutics Inc ,Technology Award Of China Association ,Company Clinical Advisory Board ,Asia Pacific Regional Council ,Chinese Society Of Clinical Oncology ,Clinical Advisory Board ,Phane Chief Medical ,Professor Shun ,Shanghai Lung Cancer Center ,Shanghai Chest Hospital ,Shanghai Jiao Tong ,Cancer Center ,Visiting Professor ,Lancet Oncology ,Lancet Respir Med ,Clin Cancer Res ,Nat Commun ,Pacific Regional Council ,Standing Director ,Deputy Secretary ,Chinese Society ,Clinical Oncology ,Board Member ,Oncology Society Chinese Medical Association ,Anticancer Association ,Associate Editor ,Thoracic Oncology ,Lung Cancer ,Editorial Board Member ,First Prize ,China Anti Cancer Association ,Shanghai Medical Science ,Shanghai Scientific ,Phanes Therapeutics ,